Life Sciences & Biotechnology
Title : | Exploring therapeutic efficacy of novel toll like receptor 9 antagonist in Type II Diabetes |
Area of Research : | Life Sciences & Biotechnology, Medical Sciences |
Focus Area : | Type II Diabetes |
Principal Investigator : | Dr. Dipyaman Ganguly, Scientist, Cancer Biology & Inflammatory Disorder, Indian Institute of Chemical Biology (IICB), Kolkata, West Bengal |
Contact info : | dipyaman@iicb.res.in |
Timeline Start Year : | 2017 |
Total Budget (INR): | 48,07,600 |
Details
Organizations involved